Rethinking Nuclear Receptors as Potential Therapeutic Targets for Retinal Diseases
Authors:
Open Access
- 1 December 2016
- journal article
- review article
- Published by Elsevier in SLAS Discovery
- Vol. 21 (10) , 1007-1018
Abstract
No abstract availableKeywords
This publication has 133 references indexed in Scilit:
- Aryl hydrocarbon receptor deficiency causes dysregulated cellular matrix metabolism and age-related macular degeneration-like pathologyProceedings of the National Academy of Sciences, 2013
- In Pursuit of Synthetic Modulators for the Orphan Retina-Specific Nuclear Receptor NR2E3Journal of Ocular Pharmacology and Therapeutics, 2012
- IDF Diabetes Atlas: Global estimates of the prevalence of diabetes for 2011 and 2030Diabetes Research and Clinical Practice, 2011
- Suppression of TH17 differentiation and autoimmunity by a synthetic ROR ligandNature, 2011
- Nr2e3-directed transcriptional regulation of genes involved in photoreceptor development and cell-type specific phototransductionExperimental Eye Research, 2009
- Nuclear receptors: Decoding metabolic diseaseFEBS Letters, 2007
- Recurrent Mutation in the First Zinc Finger of the Orphan Nuclear Receptor NR2E3 Causes Autosomal Dominant Retinitis PigmentosaThe American Journal of Human Genetics, 2007
- Principles for modulation of the nuclear receptor superfamilyNature Reviews Drug Discovery, 2004
- The RXR heterodimers and orphan receptorsCell, 1995
- Human oestrogen receptor cDNA: sequence, expression and homology to v-erb-ANature, 1986